116 related articles for article (PubMed ID: 9103520)
1. Antagonism of N-methyl-D-aspartate-evoked currents in rat cortical cultures by ARL 15896AR.
Mealing GA; Lanthorn TH; Small DL; Black MA; Laferriere NB; Morley P
J Pharmacol Exp Ther; 1997 Apr; 281(1):376-83. PubMed ID: 9103520
[TBL] [Abstract][Full Text] [Related]
2. N-methyl-D-aspartate receptor channel block by the enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL.
Grauert M; Rho JM; Subramaniam S; Rogawski MA
J Pharmacol Exp Ther; 1998 May; 285(2):767-76. PubMed ID: 9580625
[TBL] [Abstract][Full Text] [Related]
3. -(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia.
Cregan EF; Peeling J; Corbett D; Buchan AM; Saunders J; Auer RN; Gao M; Mccarthy DJ; Eisman MS; Campbell TM; Murray RJ; Stagnitto ML; Palmer GC
J Pharmacol Exp Ther; 1997 Dec; 283(3):1412-24. PubMed ID: 9400017
[TBL] [Abstract][Full Text] [Related]
4. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.
Losi G; Lanza M; Makovec F; Artusi R; Caselli G; Puia G
Neuropharmacology; 2006 Mar; 50(3):277-85. PubMed ID: 16236334
[TBL] [Abstract][Full Text] [Related]
5. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
Priestley T; Marshall GR; Hill RG; Kemp JA
Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
[TBL] [Abstract][Full Text] [Related]
6. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
Subramaniam S; Donevan SD; Rogawski MA
J Pharmacol Exp Ther; 1996 Jan; 276(1):161-8. PubMed ID: 8558426
[TBL] [Abstract][Full Text] [Related]
7. Effect of thiopental sodium on N-methyl-D-aspartate-gated currents.
Liu H; Dai T; Yao S
Can J Anaesth; 2006 May; 53(5):442-8. PubMed ID: 16636027
[TBL] [Abstract][Full Text] [Related]
8. Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine.
Gilling KE; Jatzke C; Parsons CG
Neuropharmacology; 2007 Sep; 53(3):415-20. PubMed ID: 17632186
[TBL] [Abstract][Full Text] [Related]
9. Structural modifications to an N-methyl-D-aspartate receptor antagonist result in large differences in trapping block.
Mealing GA; Lanthorn TH; Small DL; Murray RJ; Mattes KC; Comas TM; Morley P
J Pharmacol Exp Ther; 2001 Jun; 297(3):906-14. PubMed ID: 11356910
[TBL] [Abstract][Full Text] [Related]
10. The dihydropyridine nitrendipine reduces N-methyl-D-aspartate (NMDA)-evoked currents of rodent cortical neurons through a direct interaction with the NMDA receptor-associated ion channel.
Skeen GA; White HS; Twyman RE
J Pharmacol Exp Ther; 1994 Oct; 271(1):30-8. PubMed ID: 7965728
[TBL] [Abstract][Full Text] [Related]
11. Hydrophobic interactions of n-alkyl diamines with the N-methyl-D-aspartate receptor: voltage-dependent and -independent blocking sites.
Subramaniam S; Donevan SD; Rogawski MA
Mol Pharmacol; 1994 Jan; 45(1):117-24. PubMed ID: 8302270
[TBL] [Abstract][Full Text] [Related]
12. Differences in degree of trapping of low-affinity uncompetitive N-methyl-D-aspartic acid receptor antagonists with similar kinetics of block.
Mealing GA; Lanthorn TH; Murray CL; Small DL; Morley P
J Pharmacol Exp Ther; 1999 Jan; 288(1):204-10. PubMed ID: 9862772
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons.
Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T
J Pharmacol Exp Ther; 2003 Oct; 307(1):160-7. PubMed ID: 12805478
[TBL] [Abstract][Full Text] [Related]
14. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
15. Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons.
Yang XC; Reis DJ
J Pharmacol Exp Ther; 1999 Feb; 288(2):544-9. PubMed ID: 9918557
[TBL] [Abstract][Full Text] [Related]
16. The NMDA type glutamate receptors expressed by primary rat osteoblasts have the same electrophysiological characteristics as neuronal receptors.
Gu Y; Genever PG; Skerry TM; Publicover SJ
Calcif Tissue Int; 2002 Mar; 70(3):194-203. PubMed ID: 11907717
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.
Whittemore ER; Ilyin VI; Woodward RM
J Pharmacol Exp Ther; 1997 Jul; 282(1):326-38. PubMed ID: 9223571
[TBL] [Abstract][Full Text] [Related]
18. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
Parsons CG; Danysz W; Quack G; Hartmann S; Lorenz B; Wollenburg C; Baran L; Przegalinski E; Kostowski W; Krzascik P; Chizh B; Headley PM
J Pharmacol Exp Ther; 1997 Dec; 283(3):1264-75. PubMed ID: 9400002
[TBL] [Abstract][Full Text] [Related]
19. Selective neurotoxicity induced by the ionophore lasalocid in rat dissociated cerebral cultures, involvement of the NMDA receptor/channel.
Safran N; Haring R; Gurwitz D; Shainberg A; Halili I; Levy A; Bogin E; Shahar A
Neurotoxicology; 1996; 17(3-4):883-95. PubMed ID: 9086512
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of inward current evoked by N-methyl-D-aspartate in dopamine neurons in the rat brain slice.
Wu YN; Johnson SW
J Pharmacol Exp Ther; 1996 Nov; 279(2):457-63. PubMed ID: 8930146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
